Free Full-Text
Abstract
:
Circulating tumor cells (CTCs) can be detected in the blood of
different types of early or advanced cancer using immunology-based
assays or nucleic acid methods. The detection and quantification of CTCs
has significant clinical utility in the prognosis of metastatic breast,
prostate, and colorectal cancers. CTCs are a heterogeneous population
of cells and often different from those of their respective primary
tumor. Understanding the biology of CTCs may provide useful predictive
information for the selection of the most appropriate treatment.
Therefore, CTC detection and characterization could become a valuable
tool to refine prognosis and serve as a “real-time biopsy” and has the
potential to guide precision cancer therapies, monitor cancer treatment,
and investigate the process of metastasis.
- See more at:
http://www.mdpi.com/2072-6694/6/4/2369/htm#sthash.UvsIAwMW.dpuf
Abstract
:
Circulating tumor cells (CTCs) can be detected in the blood of
different types of early or advanced cancer using immunology-based
assays or nucleic acid methods. The detection and quantification of CTCs
has significant clinical utility in the prognosis of metastatic breast,
prostate, and colorectal cancers. CTCs are a heterogeneous population
of cells and often different from those of their respective primary
tumor. Understanding the biology of CTCs may provide useful predictive
information for the selection of the most appropriate treatment.
Therefore, CTC detection and characterization could become a valuable
tool to refine prognosis and serve as a “real-time biopsy” and has the
potential to guide precision cancer therapies, monitor cancer treatment,
and investigate the process of metastasis.
- See more at:
http://www.mdpi.com/2072-6694/6/4/2369/htm#sthash.UvsIAwMW.dpuf
Abstract
:
Circulating tumor cells (CTCs) can be detected in the blood of
different types of early or advanced cancer using immunology-based
assays or nucleic acid methods. The detection and quantification of CTCs
has significant clinical utility in the prognosis of metastatic breast,
prostate, and colorectal cancers. CTCs are a heterogeneous population
of cells and often different from those of their respective primary
tumor. Understanding the biology of CTCs may provide useful predictive
information for the selection of the most appropriate treatment.
Therefore, CTC detection and characterization could become a valuable
tool to refine prognosis and serve as a “real-time biopsy” and has the
potential to guide precision cancer therapies, monitor cancer treatment,
and investigate the process of metastasis.
- See more at:
http://www.mdpi.com/2072-6694/6/4/2369/htm#sthash.UvsIAwMW.dpuf
Abstract
:
Circulating tumor cells (CTCs) can be detected in the blood of
different types of early or advanced cancer using immunology-based
assays or nucleic acid methods. The detection and quantification of CTCs
has significant clinical utility in the prognosis of metastatic breast,
prostate, and colorectal cancers. CTCs are a heterogeneous population
of cells and often different from those of their respective primary
tumor. Understanding the biology of CTCs may provide useful predictive
information for the selection of the most appropriate treatment.
Therefore, CTC detection and characterization could become a valuable
tool to refine prognosis and serve as a “real-time biopsy” and has the
potential to guide precision cancer therapies, monitor cancer treatment,
and investigate the process of metastasis.
- See more at:
http://www.mdpi.com/2072-6694/6/4/2369/htm#sthash.UvsIAwMW.dpuf
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.